151 related articles for article (PubMed ID: 37249147)
1. Understanding factors influencing primary treatment with intradetrusor onabotulinumtoxinA versus augmentation cystoplasty in patients with spina bifida.
Li B; Peard LM; Zhao S; Graham MK; Adams C; Taylor AS; Thomas JC; Pope JC; Adams MC; Brock JW; Clayton DB
Neurourol Urodyn; 2023 Aug; 42(6):1431-1436. PubMed ID: 37249147
[TBL] [Abstract][Full Text] [Related]
2. Urodynamic and imaging findings in infants with myelomeningocele may predict need for future augmentation cystoplasty.
Corona LE; Lee T; Marchetti K; S Streur C; Ivancic V; Kraft KH; Bloom DA; Wan J; Park JM
J Pediatr Urol; 2019 Dec; 15(6):644.e1-644.e5. PubMed ID: 31653462
[TBL] [Abstract][Full Text] [Related]
3. Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study.
Hascoet J; Peyronnet B; Forin V; Baron M; Capon G; Prudhomme T; Allenet C; Tournier S; Maurin C; Cornu JN; Bouali O; Peycelon M; Arnaud A; Renaux-Petel M; Liard A; Karsenty G; Manunta A; Game X
Urology; 2018 Jun; 116():161-167. PubMed ID: 29522865
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes after increasing bladder outlet resistance without augmentation cystoplasty in neurogenic bladder.
Weaver JK; Coplen DE; Knight BA; Koenig JS; Vricella GJ; Vetter J; Traxel EJ; Austin PF
J Pediatr Urol; 2021 Apr; 17(2):235.e1-235.e7. PubMed ID: 33342678
[TBL] [Abstract][Full Text] [Related]
5. Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients: A single-center experience in a multidisciplinary team.
Perrouin-Verbe MA; Léon P; Denys P; Mongiat-Artus P; Chartier-Kastler E; Phé V
Neurourol Urodyn; 2019 Jan; 38(1):330-337. PubMed ID: 30350892
[TBL] [Abstract][Full Text] [Related]
6. Update on Urological Management of Spina Bifida from Prenatal Diagnosis to Adulthood.
Snow-Lisy DC; Yerkes EB; Cheng EY
J Urol; 2015 Aug; 194(2):288-96. PubMed ID: 25839383
[TBL] [Abstract][Full Text] [Related]
7. More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned.
Leitner L; Guggenbühl-Roy S; Knüpfer SC; Walter M; Schneider MP; Tornic J; Sammer U; Mehnert U; Kessler TM
Eur Urol; 2016 Sep; 70(3):522-8. PubMed ID: 27106070
[TBL] [Abstract][Full Text] [Related]
8. Intradetrusor botox injection and augmentation cystoplasty trends among spina bifida patients at US freestanding children's hospitals.
Vasdev R; Softness K; Cahill D; Panagides J; Logvinenko T; Saunders R; Bauer S; Estrada C; Wang HS
J Pediatr Urol; 2024 Feb; ():. PubMed ID: 38402080
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting the success of intradetrusor onabotulinum toxin-A treatment in children with neurogenic bladders due to myelomeningocele: The outcomes of a large cohort.
Danacioglu YO; Keser F; Ersoz C; Polat S; Avci AE; Kalkan S; Silay MS
J Pediatr Urol; 2021 Aug; 17(4):520.e1-520.e7. PubMed ID: 33712371
[TBL] [Abstract][Full Text] [Related]
10. Botulinum injection is useless on fibrotic neuropathic bladders.
Tiryaki S; Yagmur I; Parlar Y; Ozel K; Akyildiz C; Avanoglu A; Ulman I
J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
[TBL] [Abstract][Full Text] [Related]
11. How early is early? Effect of oxybutynin on bladder dynamics within the first year of life in patients with spina bifida.
Lee AS; Viseshsindh W; Long CJ; Frazier JR; Moran MH; Zderic SA; Weiss DA
J Pediatr Urol; 2020 Apr; 16(2):168.e1-168.e6. PubMed ID: 32115375
[TBL] [Abstract][Full Text] [Related]
12. The influence of bowel management on urodynamic findings in spina bifida children with detrusor overactivity and detrusor sphincter dyssynergia.
Milivojevic S; Milic N; Lazovic JM; Radojicic Z
J Pediatr Urol; 2020 Oct; 16(5):556.e1-556.e7. PubMed ID: 32376289
[TBL] [Abstract][Full Text] [Related]
13. Severe bladder trabeculation obviates the need for bladder outlet procedures during augmentation cystoplasty in incontinent patients with neurogenic bladder.
Khoury AE; Dave S; Peralta-Del Valle MH; Braga LH; Lorenzo AJ; Bägli D
BJU Int; 2008 Jan; 101(2):223-6. PubMed ID: 17970790
[TBL] [Abstract][Full Text] [Related]
14. Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism.
Peyronnet B; Even A; Capon G; De Seze M; Hascoet J; Biardeau X; Baron M; Perrouin-Verbe MA; Boutin JM; Saussine C; Phé V; Lenormand L; Chartier-Kastler E; Cornu JN; Karsenty G; Manunta A; Schurch B; Denys P; Amarenco G; Game X;
J Urol; 2018 Oct; 200(4):875-880. PubMed ID: 29746860
[TBL] [Abstract][Full Text] [Related]
15. Risk determination for upper urinary tract damage in children with neuropathic bladder.
Ekberlİ G; Taner S
J Paediatr Child Health; 2023 Jul; 59(7):863-870. PubMed ID: 36999336
[TBL] [Abstract][Full Text] [Related]
16. Imaging characteristics predicting elevated detrusor pressures in patients with spina bifida.
Hannallah A; Baker ZG; Cowan A; Bajakian T; Vasquez E; Ko JS
J Pediatr Urol; 2023 Feb; 19(1):65.e1-65.e7. PubMed ID: 36333199
[TBL] [Abstract][Full Text] [Related]
17. Need for botulinum toxin injection and bladder augmentation after isolated bladder outlet procedure in pediatric patients with myelomeningocele.
Smith MC; Strine AC; DeFoor WR; Minevich E; Noh P; Sheldon CA; Reddy PP; VanderBrink BA
J Pediatr Urol; 2020 Feb; 16(1):32.e1-32.e8. PubMed ID: 31839471
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness and safety of sacral neuromodulation on neurogenic bladder and bowel dysfunction in patients with spina bifida].
Chen G; Wang Y; Ying X; Pang D; Liao L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 Nov; 35(11):1374-1379. PubMed ID: 34779161
[TBL] [Abstract][Full Text] [Related]
19. [Urodynamic changes after bladder augmentation surgery in paediatric patients with myelomeningocele due to neurogenic bladder].
Zaragoza Torres RI; Galarza-Flores ME; Gómez-Castellanos JC; Barrera-de León JC
Cir Cir; 2016; 84(2):115-20. PubMed ID: 26707251
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin in patients at-risk for bladder augmentation: Durable impact or kicking the can?
Bowen DK; Meyer T; Rosoklija I; Sturm R; Chu DI; Cheng EY; Yerkes EB
Neurourol Urodyn; 2022 Aug; 41(6):1406-1413. PubMed ID: 35670258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
